Literature DB >> 15842183

Understanding and treating panic disorder in the primary care setting.

Peter P Roy-Byrne1, Amy W Wagner, Trevor J Schraufnagel.   

Abstract

According to studies, the median prevalence of panic disorder in the primary care setting is 4%. Rates are higher among certain patient populations, such as those with cardiac (20% to 50%) or gastrointestinal presentations (28% to 40%). Consequently, patients with panic disorder are high utilizers of medical services and are heavily represented among patients classified as high health care utilizers, compared with other psychiatric or non-psychiatric groups. Despite its frequency in the primary care setting, panic disorder is significantly under-recognized by medical providers. Corresponding with inadequate recognition is the substantial proportion of these patients who fail to receive appropriate treatment (pharmacotherapy and psychotherapy). Most experts have concluded that panic disorder is poorly managed in the primary care setting because of the process of care and patient engagement. In terms of process of care, primary care practice still operates on an acute disease model (leaving no time for initial patient education or follow-up), which is a poor fit for the management of chronic diseases. Insufficient patient engagement in treatment (i.e., being involved in the treatment process, "buying into" rationale for treatment, and being willing to collaborate with clinician and adhere to recommendations) is the second important contributor to inadequate treatment. Use of a chronic disease self-management approach would enhance treatment of panic disorder. This model requires that patients, in collaboration with the health care provider/system, take day-to-day responsibility for managing their illness by doing 3 things: adhering to recommended medical management, adopting improved health habits/coping skills, and assisting in ongoing monitoring of illness status/change. Future approaches to treating panic disorder in primary care would be enhanced by including assessments of patient beliefs and preferences, spending more time in preparing the patient for treatment, utilizing a simple pharmacotherapy algorithm, utilizing simple rating scales to monitor outcomes, and training providers in brief CBT interventions.

Entities:  

Mesh:

Year:  2005        PMID: 15842183

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  13 in total

1.  Mental health service use and treatment adequacy for anxiety disorders in Canada.

Authors:  Pasquale Roberge; Louise Fournier; Arnaud Duhoux; Cat Tuong Nguyen; Mirrian Smolders
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-03-09       Impact factor: 4.328

2.  Collaborative stepped care for anxiety disorders in primary care: aims and design of a randomized controlled trial.

Authors:  Anna D T Muntingh; Christina M van der Feltz-Cornelis; Harm W J van Marwijk; Philip Spinhoven; Willem J J Assendelft; Margot W M de Waal; Leona Hakkaart-van Roijen; Herman J Adèr; Anton J L M van Balkom
Journal:  BMC Health Serv Res       Date:  2009-09-08       Impact factor: 2.655

3.  Racial and ethnic disparities in detection and treatment of depression and anxiety among psychiatric and primary health care visits, 1995-2005.

Authors:  Susan E Stockdale; Isabel T Lagomasino; Juned Siddique; Thomas McGuire; Jeanne Miranda
Journal:  Med Care       Date:  2008-07       Impact factor: 2.983

4.  Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review.

Authors:  Boadie W Dunlop; Paula G Davis
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

5.  A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.

Authors:  Mark Pollack; Richard Mangano; Richard Entsuah; Evan Tzanis; Naomi M Simon; Ying Zhang
Journal:  Psychopharmacology (Berl)       Date:  2007-06-23       Impact factor: 4.530

Review 6.  Diagnosis and treatment of agoraphobia with panic disorder.

Authors:  Giulio Perugi; Franco Frare; Cristina Toni
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Panic disorder in primary care: comorbid psychiatric disorders and their persistence.

Authors:  Virpi Tilli; Kirsi Suominen; Hasse Karlsson
Journal:  Scand J Prim Health Care       Date:  2012-10-31       Impact factor: 2.581

Review 8.  Dietary and botanical anxiolytics.

Authors:  Elham Alramadhan; Mirna S Hanna; Mena S Hanna; Todd A Goldstein; Samantha M Avila; Benjamin S Weeks
Journal:  Med Sci Monit       Date:  2012-04

9.  Is the Beck Anxiety Inventory a good tool to assess the severity of anxiety? A primary care study in the Netherlands Study of Depression and Anxiety (NESDA).

Authors:  Anna D T Muntingh; Christina M van der Feltz-Cornelis; Harm W J van Marwijk; Philip Spinhoven; Brenda W J H Penninx; Anton J L M van Balkom
Journal:  BMC Fam Pract       Date:  2011-07-04       Impact factor: 2.497

10.  Implementing a knowledge application program for anxiety and depression in community-based primary mental health care: a multiple case study research protocol.

Authors:  Pasquale Roberge; Louise Fournier; Hélène Brouillet; Catherine Hudon; Janie Houle; Martin D Provencher; Jean-Frédéric Lévesque
Journal:  Implement Sci       Date:  2013-03-04       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.